
MDGL
USDMadrigal Pharmaceuticals Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$488.030
Максимум
$494.550
Минимум
$477.000
Объем
0.76M
Фундаментальные показатели компании
Рыночная капитализация
11.1B
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
0.37M
Биржа
NMS
Валюта
USD
52-недельный диапазон
Связанные новости
B of A Securities Upgrades Madrigal Pharmaceuticals to Neutral, Raises Price Target to $445
B of A Securities analyst Alexandria Hammond upgrades Madrigal Pharmaceuticals from Underperform to Neutral and raises the price target from $266 to $445.
Madrigal to Present New Data from the Company's MASH Program at AASLD's The Liver Meeting 2025
Two oral presentations to highlight biomarker, imaging and quality-of-life data from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial of RezdiffraPoster of distinction examines the
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
CONSHOHOCKEN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated
Truist Securities Initiates Coverage On Madrigal Pharmaceuticals with Buy Rating, Announces Price Target of $580
Truist Securities analyst Srikripa Devarakonda initiates coverage on Madrigal Pharmaceuticals with a Buy rating and announces Price Target of $580.
Связанные акции
ESRT
Empire State Realty Trust Inc.
CDP
COPT Defense Properties Common Shares of Beneficial Interest
VCNX
Vaccinex Inc.
EOSE
Eos Energy Enterprises Inc.
PNI
Pimco New York Municipal Income Fund II Common Shares of Beneficial Interest
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.